IO Biotech

Performance

About IO Biotech

IO Biotech is a biotechnology company focused on developing first-in-class cancer vaccines that modulate the tumor microenvironment to enhance anti-tumor immune response. The company emphasizes off-the-shelf, immune-modulatory vaccines (notably its T-win platform) designed to kill tumor cells and suppressive immune cells, with a primary focus on melanoma and other tumor types. Their work spans research, programs, and clinical development, aiming to establish combination therapy foundations for cancer treatment. IO Biotech is headquartered in the biotechnology ecosystem, with leadership and activities highlighted in recent company communications and investor materials.